3-(Toluene-4-sulfonyloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 2g

3-((Tert-butoxycarbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95%, 5g

N*1*-(2-Nitro-4-trifluoromethyl-phenyl)-ethane-1,2-diamine, 98%, 1g

2-Azabicyclo[2.1.1]hexane hydrochloride, 95.0%, 10g

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.20 mm, 0.35 µm, 1 Piece(s)

6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid), 97%, 5g

4-Amino-6-chloronicotinic acid, 95.0%, 25g

N-(4-amino-2,5-dimethoxyphenyl)benzamide, 98%, 100g

N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide, 98%, 250mg

Benzyl (2-aminobenzoyl)glycinate, 95+%, 5g

3-Amino-2-methylpyridine, 98.0%, 25g

6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one compound with 2-aminoethanol (1:1), 95.0%, 25g

2-Deoxy-3,5-di-O-p-toluoyl-D-erythro-pentofuranosyl chloride, 98%, 100mg